COMMUNIQUÉ DE PRESSE publié le 14/06/2024 à 14:52, il y a 1 année 9 mois Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research increases Cardiol Therapeutics Inc's price target to USD8.50 in Buy recommendation after positive results from phase II trial of CardiolRx for recurrent pericarditis treatment Cardiol Therapeutics Inc First Berlin Equity Research Buy Recommendation Phase II Trial CardiolRx
COMMUNIQUÉ DE PRESSE publié le 27/02/2024 à 14:16, il y a 2 années Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates BUY recommendation on Cardiol Therapeutics Inc. FDA grants Orphan Drug Designation for CardiolRx in pericarditis treatment. Positive phase II study results expected in Q2 2024 FDA Cardiol Therapeutics Inc First Berlin Equity Research Orphan Drug Designation Pericarditis
BRÈVE publiée le 27/02/2024 à 14:16, il y a 2 années Cardiol Therapeutics Receives FDA Orphan Drug Designation for CardiolRx FDA Investment Orphan Drug Designation Cardiol Therapeutics Pericarditis
BRÈVE publiée le 27/02/2024 à 14:16, il y a 2 années Cardiol Therapeutics obtient la désignation de médicament orphelin par la FDA pour CardiolRx Investissement FDA Orphan Drug Designation Cardiol Therapeutics Pericardite
COMMUNIQUÉ DE PRESSE publié le 19/01/2024 à 12:41, il y a 2 années 2 mois Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research has published an update on Cardiol Therapeutics Inc., reaffirming its BUY recommendation and maintaining the price target of USD 3.60. The report highlights the progress in patient recruitment for CardiolRx's two lead indications, acute myocarditis (AM) and recurrent pericarditis (RP), with expectations of significant near-term catalysts for the stock. Analyst Christian Orquera remains optimistic about the company's investment potential. For the full analysis, visit the link provided. Cardiol Therapeutics Inc First Berlin Equity Research Buy Recommendation Patient Recruitment Investment Potential
COMMUNIQUÉ DE PRESSE publié le 30/08/2023 à 15:06, il y a 2 années 6 mois Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
COMMUNIQUÉ DE PRESSE publié le 24/05/2023 à 13:01, il y a 2 années 9 mois Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
COMMUNIQUÉ DE PRESSE publié le 11/04/2023 à 15:26, il y a 2 années 11 mois Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
Publié le 20/03/2026 à 19:00, il y a 1 jour 10 heures AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Publié le 20/03/2026 à 19:00, il y a 1 jour 10 heures AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Publié le 20/03/2026 à 18:15, il y a 1 jour 11 heures Publication of AXA’s 2025 Universal Registration Document
Publié le 20/03/2026 à 18:15, il y a 1 jour 11 heures Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
Publié le 20/03/2026 à 13:30, il y a 1 jour 16 heures Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Publié le 20/03/2026 à 12:30, il y a 1 jour 17 heures CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals
Publié le 20/03/2026 à 22:45, il y a 1 jour 7 heures Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Publié le 20/03/2026 à 21:05, il y a 1 jour 8 heures Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Publié le 20/03/2026 à 21:05, il y a 1 jour 8 heures Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Publié le 20/03/2026 à 21:00, il y a 1 jour 8 heures BRP Unveils the Winners of its 6th International Design Challenge
Publié le 20/03/2026 à 20:05, il y a 1 jour 9 heures INVESTOR ALERT: Goeasy Ltd. Shareholder Class Action